title: The use of intra-detrusor onabotulinumtoxinA in patients with myasthenia gravis.
abstract: The use of intra-detrusor onabotulinumtoxinA (Botox®) in patients with myasthenia gravis has not been reported, and little evidence exists to substantiate a complete contraindication of Botox use in this population. Here, we present two cases of comorbid overactive bladder (OAB) and myasthenia gravis successfully treated with intra-detrusor Botox.
authors: Alberta Cancer Centre, Calgary, AB, Canada.
authors: Ian
authors: I
authors: Wright
authors: Alberta Cancer Centre, Calgary, AB, Canada.
authors: Andrea
authors: A
authors: Civitarese
authors: Alberta Cancer Centre, Calgary, AB, Canada;; Univesity of Calgary, Calgary, AB, Canada.
authors: Richard
authors: R
authors: Baverstock